https://mindmedicinelaw.com/briefing/fda-s-final-debarment-of-rahim-shafa-implications-for-psychedelic-sector-20260831-37193The Psychedelic Journalen2026-08-31T15:05:23.928946+00:00FDA's Final Debarment of Rahim Shafa: Implications for Psychedelic SectorFDA debarment, Rahim Shafa, psychedelic regulation, FD&C Act, drug importation, compliance strategies, pharmaceutical industry, psychedelic research, regulatory enforcement, legal consequenceshttps://mindmedicinelaw.com/briefing/neuroimaging-study-maps-brain-networks-in-dissociative-symptoms-20260829-37210The Psychedelic Journalen2026-08-31T15:05:48.679361+00:00Neuroimaging Study Maps Brain Networks in Dissociative Symptomsdissociative symptoms, neuroimaging, brain networks, psychiatric disorders, psychedelic research, neurotransmitter associations, therapeutic interventions, clinical trialshttps://mindmedicinelaw.com/briefing/neurophysiological-insights-from-meditation-in-tibetan-monks-20260829-37246The Psychedelic Journalen2026-08-31T15:05:34.904218+00:00Neurophysiological Insights from Meditation in Tibetan Monksneurophysiological signatures, meditation practices, Tibetan monks, autonomic-cortical integration, mental health benefits, study design limitations, emotional regulation, cognitive flexibility, EEG analysis, parasympathetic activityhttps://mindmedicinelaw.com/briefing/ketamine-s-role-in-treatment-resistant-depression-mechanisms-and-implications-20260828-37258The Psychedelic Journalen2026-08-31T15:06:00.079434+00:00Ketamine's Role in Treatment-Resistant Depression: Mechanisms and Implicationsketamine, treatment-resistant depression, glutamatergic neurotransmission, neuroplasticity, NMDA receptors, AMPA receptors, BDNF signaling, mTOR pathways, antidepressant effectshttps://mindmedicinelaw.com/briefing/mdma-therapy-for-ptsd-systematic-review-insights-20260828-37230The Psychedelic Journalen2026-08-31T15:05:08.898954+00:00MDMA Therapy for PTSD: Systematic Review InsightsMDMA-assisted therapy, PTSD treatment, depressive symptoms, systematic review, clinical guidelines, psychedelic research, mental health, FDA approval, psychedelic-assisted therapy, public healthhttps://mindmedicinelaw.com/briefing/psychedelics-in-psychiatry-lessons-from-intranasal-esketamine-20260828-36880The Psychedelic Journalen2026-08-30T15:05:24.061161+00:00Psychedelics in Psychiatry: Lessons from Intranasal Esketaminepsychedelics in psychiatry, intranasal esketamine, psychedelic therapies, mental disorders treatment, clinical trials, neuroscience, psychedelic safety, psychedelic commercializationhttps://mindmedicinelaw.com/briefing/ect-s-impact-on-brain-networks-insights-for-psychedelic-research-20260828-36925The Psychedelic Journalen2026-08-30T15:05:14.401858+00:00ECT's Impact on Brain Networks: Insights for Psychedelic Researchelectroconvulsive therapy, brain networks, synaptic plasticity, depression treatment, psychedelic therapy, functional connectivity, neurotransmission, neurotrophic factors, inflammatory responses, mental health researchhttps://mindmedicinelaw.com/briefing/rna-sequencing-in-depressive-disorders-progress-and-challenges-20260828-36927The Psychedelic Journalen2026-08-30T15:05:06.245275+00:00RNA Sequencing in Depressive Disorders: Progress and ChallengesRNA sequencing, depressive disorders, precision medicine, molecular mechanisms, clinical translation, data heterogeneity, single-cell transcriptomics, immune-inflammatory activation, personalized treatment, neuroendocrine-immune interactionhttps://mindmedicinelaw.com/briefing/lc-ms-ms-hair-analysis-reveals-drug-use-trends-at-brazilian-festivals-20260828-36938The Psychedelic Journalen2026-08-30T15:04:56.877200+00:00LC-MS/MS Hair Analysis Reveals Drug Use Trends at Brazilian FestivalsLC-MS/MS hair analysis, drug use patterns, electronic dance music festivals, polysubstance use, public health strategies, Brazilhttps://mindmedicinelaw.com/briefing/interoceptive-interventions-and-anxiety-sensitivity-a-review-20260828-36881The Psychedelic Journalen2026-08-30T15:04:47.185239+00:00Interoceptive Interventions and Anxiety Sensitivity: A Reviewinteroceptive interventions, anxiety sensitivity, mindfulness, cognitive behavioral therapy, occupational therapy, public health, mental health, systematic review, neuroscience, clinical trialshttps://mindmedicinelaw.com/briefing/natural-medicines-neurogenesis-depression-treatment-review-20260828-36882The Psychedelic Journalen2026-08-30T15:04:36.976182+00:00Natural Medicines & Neurogenesis: Depression Treatment Reviewnatural medicines, neurogenesis, depression treatment, major depressive disorder, clinical trials, biomarker-stratified trials, safety assessment, brain-derived neurotrophic factor, adjunctive therapies, phytochemicalshttps://mindmedicinelaw.com/briefing/lipid-metabolism-s-role-in-fluoxetine-s-efficacy-for-trd-20260828-36924The Psychedelic Journalen2026-08-30T15:04:28.627047+00:00Lipid Metabolism's Role in Fluoxetine's Efficacy for TRDlipid metabolism, fluoxetine, immunomodulatory effects, treatment-resistant depression, macrophages, LDLR pathway, antidepressant efficacy, lipid landscape, metabolic disruptionshttps://mindmedicinelaw.com/briefing/integrating-medicinal-plants-and-spirituality-in-health-practices-20260824-36943The Psychedelic Journalen2026-08-30T15:05:32.912693+00:00Integrating Medicinal Plants and Spirituality in Health Practicesmedicinal plants, spirituality, traditional health practices, cultural contexts, integrative research, pharmacognosy, therapeutic potential, healthcare policy, ethical concerns, holistic healthcarehttps://mindmedicinelaw.com/briefing/dmt-s-chemical-structure-and-mystical-effects-an-analysis-20260823-36944The Psychedelic Journalen2026-08-30T15:05:49.830785+00:00DMT's Chemical Structure and Mystical Effects: An Analysisdmt, psychedelic research, consciousness studies, therapeutic potential, serotonin, ayahuasca, neuroscience, psychiatry, chemical structure, subjective effectshttps://mindmedicinelaw.com/briefing/dmt-s-chemical-mysteries-and-therapeutic-potential-20260823-36945The Psychedelic Journalen2026-08-30T15:05:42.440968+00:00DMT's Chemical Mysteries and Therapeutic PotentialDMT, psychoactive substances, ayahuasca, serotonin, brain connectivity, psychiatric therapy, consciousness, Indigenous practices, pharmacology, neuroscience